Introduction Executive Summary GABA A receptor agonist: Overview • Structure • Mechanism of Action Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type GABA A receptor agonist – DelveInsight’s Analytical Perspective In-depth Commercial Assessment • GABA A receptor agonist companies’ collaborations, Licensing, Acquisition -Deal Value Trends GABA A receptor agonist Collaboration Deals • Company-Company Collaborations (Licensing / Partnering) Analysis • Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) • Comparative Analysis Ganaxolone: Marinus Pharmaceuticals • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II/III) • Comparative Analysis Padsevonil: UCB Biopharma • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis Darigabat: Cerevel Therapeutics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Pre-clinical and Discovery Stage Products • Comparative Analysis Drug Name: Company Name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis GABA A receptor agonist Key Companies GABA A receptor agonist Key Products GABA A receptor agonist- Unmet Needs GABA A receptor agonist- Market Drivers and Barriers GABA A receptor agonist- Future Perspectives and Conclusion GABA A receptor agonist Analyst Views GABA A receptor agonist Key Companies Appendix

Table 1 Total Products for GABA A receptor agonist Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Marinus Pharmaceuticals • UCB Biopharma • Confluence Pharmaceuticals • Cerevel Therapeutics • Sichuan Haisco Pharmaceutical • Ovid Therapeutics